This post is the fifth in our five-part series, Navigating Life Sciences Transactions, where our team of attorneys provides essential strategies and insights for successful life sciences transactions. Throughout this series,...more
Exiting a business, whether you are a serial entrepreneur looking to move on to the next project or a healthcare provider like a physician or therapist who has nurtured your practice for decades, can be difficult. After all,...more
7/9/2024
/ Business Ownership ,
Buyers ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Due Diligence ,
Exit Strategies ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Private Equity ,
Regulatory Standards ,
Sellers ,
Target Company ,
Transparency ,
Valuation
Part III: Due Diligence-
This is the third article in our series on “Closing a Private Equity Transaction.” In Part I, the benefits of preparing for a transaction were explained, along with how best to prepare. In Part II,...more